Home/Filings/4/0001140361-13-022579
4//SEC Filing

Wood Mark 4

Accession 0001140361-13-022579

CIK 0001048477other

Filed

May 22, 8:00 PM ET

Accepted

May 23, 6:25 PM ET

Size

20.8 KB

Accession

0001140361-13-022579

Insider Transaction Report

Form 4
Period: 2013-05-22
Wood Mark
VP, Human Resources
Transactions
  • Exercise/Conversion

    Common Stock

    2013-05-22$14.39/sh+938$13,49821,215 total
  • Exercise/Conversion

    Common Stock

    2013-05-22$21.51/sh+833$17,91822,048 total
  • Exercise/Conversion

    Common Stock

    2013-05-22$26.49/sh+812$21,51022,860 total
  • Exercise/Conversion

    Common Stock

    2013-05-22$37.46/sh+520$19,47923,380 total
  • Sale

    Common Stock

    2013-05-22$67.12/sh3,103$208,28320,277 total
  • Exercise/Conversion

    Stock Option (right to buy) Common Stock

    2013-05-229380 total
    Exercise: $14.39From: 2009-11-12Exp: 2019-05-11Common Stock (938 underlying)
  • Exercise/Conversion

    Stock Option (right to buy) Common Stock

    2013-05-228335,837 total
    Exercise: $21.51From: 2010-11-12Exp: 2020-05-11Common Stock (833 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2013-05-2281215,339 total
    Exercise: $26.49From: 2011-11-12Exp: 2021-05-11Common Stock (812 underlying)
  • Exercise/Conversion

    Stock Option (right to buy) Common Stock

    2013-05-2252016,150 total
    Exercise: $37.46From: 2012-11-08Exp: 2022-05-07Common Stock (520 underlying)
Footnotes (7)
  • [F1]Transaction made pursuant to a Rule 10b5-1 plan executed on August 13, 2012.
  • [F2]The price in Column 4 is a weighted average price. The prices actually received ranged from $65.19 to $68.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F3]Original option grant vests 6/48th on November 12, 2009 and 1/48th each on the 12th of each month thereafter.
  • [F4]Original option grant vests 6/48th on November 12, 2010 and 1/48th each on the 12th of each month thereafter. Remarks:
  • [F5]Original option grant vests 6/48th on November 12, 2011 and 1/48th each on the 12th of each month thereafter.
  • [F6]Original option grant vests 6/48th on November 8, 2012 and 1/48th each on the 8th of each month thereafter.
  • [F7]Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.

Documents

1 file

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1
  • filerCIK 0001401782

Filing Metadata

Form type
4
Filed
May 22, 8:00 PM ET
Accepted
May 23, 6:25 PM ET
Size
20.8 KB